Scott Storrer '89 Promoted to CEO at Strand Life Sciences

July 1, 2015

Scott A. Storrer, a 1989 graduate of DePauw University, has today been appointed chief executive officer of Strand Life Sciences, a global genomic profiling company that uses next generation sequencing technology to empower cancer care.

Storrer had been serving as the company's global president. "In his expanded role as now president and CEO, he will be responsible for all strategy, business expansion and worldwide operations effective immediately," notes an announcement. "Storrer has overseen the company's U.S. launch of StrandAdvantage, which accelerates the analysis of therapeutically actionable cancer genes and matches them to relevant FDA-approved targeted cancer therapies and open clinical trials without the need for multiple tests."

"Scott's twenty-plus years of executive experience leading and growing profitable businesses in the healthcare industry across the payer, provider and personalized medicine sectors will help Strand develop a strong presence globally," says Vijay Chandru, who has served as Strand's chairman and CEO since its founding in 2000 and will continue in his role as chairman of the board of directors. "His move into our CEO post following me reflects the planned progression of our company and shift in focus to new products for use by physicians. I am excited to work with him and our board members as we build a dominant market position for StrandAdvantage."

Storrer added: "Strand is at a significant point in its global expansion and product roll-out. We recently introduced a new version of StrandAdvantage that features a panel that examines 152 genes -- all genes and pathways known to be impacted by existing targeted cancer therapies plus additional chemotherapeutic toxicity and resistance data. I look forward to making this important development in genomic testing widely available to oncologists and pathologists."

Storrer, who joined Strand Life Sciences in July 2014 as president of North America, will also oversee the continued expansion of Strand Life Sciences' genomics software business. He was previously president and CEO of Genomind, a personalized medicine company, and CEO of Medecision, a population health-management solutions company. Before this, he held several leadership positions with Cardinal Health, where he advanced to group president of Cardinal's $81 billion pharmaceutical segment. Earlier in his career, Storrer was executive vice president, service and information technology with CIGNA Corp.

An economics major at DePauw, Scott Storrer earned an M.B.A. from Boston University.